Polish Registry of Common Carotid Artery Access for TAVI
NCT ID: NCT03361007
Last Updated: 2020-10-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2018-01-01
2024-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Polish Transcatheter Aortic Valve-in-Valve Implantation (ViV-TAVI) Registry
NCT03361046
Aortic Valve replAcement in eLective Patients From aOrtic Valve multiceNter Registry
NCT05308173
ChAracterization of Patients and Treatment OUtcomes in Severe Tricuspid Regurgitation
NCT06838611
Safety and Performance Study of the Optimum Transcatheter Aortic Valve
NCT04076150
EffecTAVI Registry
NCT05235555
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Duration of this study is expected to be 6 years to ensure that all of the enrolled patients will complete at least 2 years of follow-up.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Common carotid artery access for TAVI
Patients in whom femoral artery could not be used to deliver the bioprosthesis for any reason.
Transcatheter Aortic Valve Implantation (TAVI)
Patients who were disqualified from surgical cortical valve replacement by decision of the Heart Team.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcatheter Aortic Valve Implantation (TAVI)
Patients who were disqualified from surgical cortical valve replacement by decision of the Heart Team.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient provided written informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Warsaw
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zenon Huczek, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Warsaw
Radosław Wilimski, MD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Warsaw
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Gdansk
Gdansk, , Poland
Medical University of Silesia
Katowice, , Poland
Medical University of Lodz
Lodz, , Poland
University of Opole
Opole, , Poland
Poznan University of Medical Sciences
Poznan, , Poland
Medical University of Warsaw
Warsaw, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Dariusz Jagielak, MD, PhD
Role: primary
Wojciech Wojakowski, MD, PhD
Role: primary
Andrzej Walczak, MD, PhD
Role: primary
Jerzy Sacha, MD, PhD
Role: primary
Marek Grygier, MD, PhD
Role: primary
Zenon Huczek, MD, PhD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Huczek Z, Wilimski R, Kochman J, Szczudlik P, Scislo P, Rymuza B, Kaplon-Cieslicka A, Kolasa A, Marchel M, Filipiak KJ, Cichon R, Opolski G. Common carotid artery access for transcatheter aortic valve implantation. Kardiol Pol. 2015;73(7):478-84. doi: 10.5603/KP.2015.0122.
Azmoun A, Amabile N, Ramadan R, Ghostine S, Caussin C, Fradi S, Raoux F, Brenot P, Nottin R, Deleuze P. Transcatheter aortic valve implantation through carotid artery access under local anaesthesia. Eur J Cardiothorac Surg. 2014 Oct;46(4):693-8; discussion 698. doi: 10.1093/ejcts/ezt619. Epub 2014 Jan 14.
Schirmer J, Conradi L, Seiffert M, Koschyk D, Blankenberg S, Reichenspurner H, Diemert P, Treede H. Transcatheter aortic valve implantation: alternative access options. Minerva Cardioangiol. 2013 Aug;61(4):429-35.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WUM-CCA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.